iShares Evolved U.S. Innovative Healthcare ETF (IEIH)
iShares Evolved U.S. Innovative Healthcare ETF operates in the Asset Management industry of the Financial Services sector, headquartered in San Francisco, CA, US. The stock last traded at $34.13, down 0.00% on the session, giving a market capitalisation of $36.8M. Its beta of 0.58 implies it has historically moved less than the broad market.
The iShares Evolved U.S. Innovative Healthcare ETF (IEIH) primarily allocates its capital to the equity securities of U.S.-based pharmaceutical and biotechnology companies. Under typical market conditions, a minimum of 80% of the fund's net assets will be invested in the common stocks of firms across various market capitalizations, including large, mid, and small-cap companies. The ETF also targets enterprises categorized within the "Innovative Healthcare Evolved Sector" — specifically, those whose financial profiles have historically aligned with conventional pharmaceutical and biotechnology businesses. It is important to note that this fund operates as a non-diversified investment vehicle.
iShares Evolved U.S. Innovative Healthcare ETF is most often compared with the following Financial Services names: